Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.230
+0.100 (3.19%)
Nov 21, 2025, 4:00 PM EST - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $124.66 million as of November 21, 2025. Its market cap has decreased by -57.77% in one year.
Market Cap
124.66M
Enterprise Value
24.72M
1-Year Change
-57.77%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $124.66M, a decrease of -74.46%. That is a compound annual growth rate of -26.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 124.66M | -54.65% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |